These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8402502)
1. Aggressive chemotherapy, organ-preserving surgery, and high-dose-rate remote brachytherapy in the treatment of rhabdomyosarcoma in infants and young children. Nag S; Grecula J; Ruymann FB Cancer; 1993 Nov; 72(9):2769-76. PubMed ID: 8402502 [TBL] [Abstract][Full Text] [Related]
2. Innovation in the management of soft tissue sarcomas in infants and young children: high-dose-rate brachytherapy. Nag S; Martínez-Monge R; Ruymann F; Jamil A; Bauer C J Clin Oncol; 1997 Sep; 15(9):3075-84. PubMed ID: 9294470 [TBL] [Abstract][Full Text] [Related]
3. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas. Nag S; Tippin D; Ruymann FB J Pediatr Hematol Oncol; 2003 Jun; 25(6):448-52. PubMed ID: 12794522 [TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy in childhood sarcomas: a local control strategy preserving bone growth and function. Nag S; Olson T; Ruymann F; Teich S; Pieters R Med Pediatr Oncol; 1995 Dec; 25(6):463-9. PubMed ID: 7565309 [TBL] [Abstract][Full Text] [Related]
5. Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma. Chargari C; Haie-Meder C; Guérin F; Minard-Colin V; de Lambert G; Mazeron R; Escande A; Marsolat F; Dumas I; Deutsch E; Valteau-Couanet D; Audry G; Oberlin O; Martelli H Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):352-359. PubMed ID: 28463154 [TBL] [Abstract][Full Text] [Related]
6. Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study. Donaldson SS; Asmar L; Breneman J; Fryer C; Glicksman AS; Laurie F; Wharam M; Gehan EA Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):903-11. PubMed ID: 7607964 [TBL] [Abstract][Full Text] [Related]
7. Conservative surgery with combined high dose rate brachytherapy for patients suffering from genitourinary and perianal rhabdomyosarcoma. Fuchs J; Paulsen F; Bleif M; Lamprecht U; Weidner N; Zips D; Neunhoeffer F; Seitz G Radiother Oncol; 2016 Nov; 121(2):262-267. PubMed ID: 27793447 [TBL] [Abstract][Full Text] [Related]
8. Long-term sequelae of conservative treatment by surgery, brachytherapy, and chemotherapy for vulval and vaginal rhabdomyosarcoma in children. Flamant F; Gerbaulet A; Nihoul-Fekete C; Valteau-Couanet D; Chassagne D; Lemerle J J Clin Oncol; 1990 Nov; 8(11):1847-53. PubMed ID: 2230871 [TBL] [Abstract][Full Text] [Related]
9. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
10. Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcoma. Lobo S; Gaze MN; Slater O; Hoskin P; Sands G; Sullivan T; Cho A; Eminowicz G; Smeulders N Pediatr Blood Cancer; 2022 Aug; 69(8):e29574. PubMed ID: 35044080 [TBL] [Abstract][Full Text] [Related]
11. AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma. Vaarwerk B; Hol MLF; Schoot RA; Breunis WB; de Win MML; Westerveld H; Fajardo RD; Saeed P; van den Brekel MW; Pieters BR; Strackee SD; Smeele LE; Merks JHM Radiother Oncol; 2019 Feb; 131():21-26. PubMed ID: 30773183 [TBL] [Abstract][Full Text] [Related]
12. Brachytherapy for solid tumors in children. Nag S Indian J Pediatr; 1996; 63(4):453-7. PubMed ID: 10832465 [TBL] [Abstract][Full Text] [Related]
13. Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience. Martelli H; Haie-Meder C; Branchereau S; Franchi-Abella S; Ghigna MR; Dumas I; Bouvet N; Oberlin O J Pediatr Surg; 2009 Jan; 44(1):190-6. PubMed ID: 19159742 [TBL] [Abstract][Full Text] [Related]
14. A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma. Regine WF; Fontanesi J; Kumar P; Zeitzer K; Greenwald C; Bowman L; Shapiro DN; Rao BN; Kun LE Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):799-805. PubMed ID: 7860391 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer. Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517 [TBL] [Abstract][Full Text] [Related]
16. Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results. Chargari C; Martelli H; Guérin F; Bacorro W; de Lambert G; Escande A; Minard-Colin V; Dumas I; Deutsch E; Haie-Meder C Radiother Oncol; 2017 Aug; 124(2):285-290. PubMed ID: 28760484 [TBL] [Abstract][Full Text] [Related]
17. Conservative treatment for lower gynecological tract malignancies in children and adolescents: the Institut Gustave-Roussy experience. Gerbaulet AP; Esche BA; Haie CM; Castaigne D; Flamant F; Chassagne D Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):655-8. PubMed ID: 2777654 [TBL] [Abstract][Full Text] [Related]
18. Brachytherapy in the combined modality treatment of pediatric malignancies. Principles and preliminary experience with treatment of soft tissue sarcoma (recurrence) and Ewing's sarcoma. Pötter R; Knocke TH; Kovacs G; Schmilowski GM; Haverkamp U; Hawliczek R; Seitz W; Rübe C; Wuisman P; Maragakis G Klin Padiatr; 1995; 207(4):164-73. PubMed ID: 7564147 [TBL] [Abstract][Full Text] [Related]
19. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929 [TBL] [Abstract][Full Text] [Related]
20. Patient outcome study of concurrent chemoradiation, external beam radiotherapy, and high-dose rate brachytherapy in locally advanced carcinoma of the cervix. Forrest JL; Ackerman I; Barbera L; Barnes EA; Davidson M; Kiss A; Thomas G Int J Gynecol Cancer; 2010 Aug; 20(6):1074-8. PubMed ID: 20683420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]